Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 12, 2026 · Other material event · Item 5.07
Lineage Cell Therapeutics, Inc.
4
Other material event
Jun 12, 2026
| Form type | Current report (Form 8-K) |
| Event summary | Other material event · Item 5.07 |
| Primary topic | Other material event |
| About this form | Public companies file this within four business days when something important happens that investors should know about, before the next quarterly report. |
| Why this was filed | Lineage Cell Therapeutics, Inc. filed this to release information to investors under Regulation FD, usually a press release, conference presentation, or other event the company considers important. ) 2173 Salk Avenue, Suite 200 Carlsbad , California 92008 (Address of Principal Executive Offices) (Zip Code) Registrant’s Telephone Number, Including Area Code: (442) 287-8990 (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the… |
| Labor angle | Watch for Item 2.05 (restructuring or severance), Item 5.02 (leadership changes), and Item 1.01 (major contracts that can precede workforce shifts). |
| Period of report | Jun 9, 2026 |
| Accession number | 0001193125-26-269557 |
| Reported items | Item 5.07, Other events the company considers material See Analysis tab for workforce implications |
